Delivery Order SPE2DR25D1202-SPE2DR26F74DV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in an 18ML pack configuration, valued at $10,776.17 under a firm fixed-price contract type. The award, issued on December 15, 2025, with an ultimate completion date of December 16, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a delivery order valued at $2,323.80 to AmerisourceBergen Drug Corp for Provocholine Inhalation Solution in an 18ML pack. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 21, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor, is the subsidiary of parent company Cencora, Inc., and serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $5,501.30 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order is a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,597.80 to AmerisourceBergen Drug Corp for Provocholine Inhalation Solution in an 18 mL pack. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 16, 2025. The delivery order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order leverages AmerisourceBergen's existing indefinite delivery...
- The Defense Logistics Agency awarded a $3,897.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Provocholine Inhalation Solution in an 18ml pack, with a completion date of January 12, 2026. This non-set-aside contract was competitively awarded on January 9, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Provocholine Inhalation Solution in 18ml pack quantities, with a contract ceiling value of $9,767.18. This non-competitive delivery order represents a firm fixed price transaction with a completion date of October 24, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,388.80 to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with performance completion targeted for November 19, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $7,459.23 to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with an ultimate completion date of November 4, 2025. This contract was competitively awarded without set-aside designation and utilizes firm fixed price pricing. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Provocholine Inhalation Solution in an 18mL pack configuration, with a firm fixed price ceiling value of $7,052.01. The award was made on December 11, 2025, with an ultimate completion date of December 12, 2025, and represents a non-set-aside, competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $1,598.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Provocholine Inhalation Solution in an 18ML pack (NSN 4570460278). The contract, issued on January 10, 2026, with an ultimate completion date of January 12, 2026, represents a routine pharmaceutical supply delivery executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order is unclassified as a set-aside and will be...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F74DVDelivery Order
The Defense Logistics Agency awarded a $2,131.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Provocholine Inhalation Solution Pack 18ML, with a completion date of January 22, 2026. This non-competitive award represents a single delivery order utilizing the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, with performance occurring at its corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s significant $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical, which extends through December 2031 and provides a comprehensive global pharmaceutical support vehicle for military healthcare programs. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. Provocholine is a diagnostic agent used in bronchial challenge testing, supporting the company's role in delivering specialized pharmaceutical products to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 1/20/26 |